Market Minds Advisory

Let's shape this report
around your question

Tell us what you'd like added, extended, or refined. You'll receive a scoping note and cost estimate within two business days.

REPORT IN CONTEXT

Gene Therapy in CNS Disorder Market: AAV Vector Platforms, Rare Disease Pipelines, and Regulatory Pathway Innovation

PublishedSep 2026
Pages337
Horizon2026-2036
LEAD ANYLYST
AB
Alice BallengerHead of Research · Healthcare